SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-122375
Filing Date
2019-04-26
Accepted
2019-04-26 16:15:55
Documents
8
Period of Report
2019-06-05
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d650507ddef14a.htm DEF 14A 340631
2 GRAPHIC g650507g11y77.jpg GRAPHIC 26592
3 GRAPHIC g650507g21j11.jpg GRAPHIC 24658
4 GRAPHIC g650507g39o49.jpg GRAPHIC 15562
5 GRAPHIC g650507g56z83.jpg GRAPHIC 16586
6 GRAPHIC g650507g57f70.jpg GRAPHIC 22487
7 GRAPHIC g650507g66d23.jpg GRAPHIC 33587
8 GRAPHIC g650507g84y44.jpg GRAPHIC 22433
  Complete submission text file 0001193125-19-122375.txt   565674
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38268 | Film No.: 19771948
SIC: 2836 Biological Products, (No Diagnostic Substances)